Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats (Q71227063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

T Tzschentke

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

W Hauber

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

115-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

17 October 2019

cites work

1 reference

12 December 2020

Effects of the novel 5-HT1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats

1 reference

12 December 2020

Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse

1 reference

12 December 2020

Behavioural pharmacology of glutamate in the basal ganglia

1 reference

12 December 2020

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

12 December 2020

Over-additive anticonvulsant effect of memantine and NBQX in kindled rats

1 reference

12 December 2020

The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.

1 reference

12 December 2020

The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.

1 reference

12 December 2020

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

12 December 2020

Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks

1 reference

12 December 2020

AMPA receptor antagonists and local cerebral glucose utilization in the rat.

1 reference

12 December 2020

Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.

1 reference

12 December 2020

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

1 reference

12 December 2020

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy

1 reference

12 December 2020

Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system

1 reference

12 December 2020

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

1 reference

12 December 2020

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

12 December 2020

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

1 reference

12 December 2020

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

12 December 2020

Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

1 reference

12 December 2020

AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.

1 reference

12 December 2020

NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil.

1 reference

12 December 2020

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

1 reference

12 December 2020

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1 reference

12 December 2020

A rapid method for the regional dissection of the rat brain

1 reference

12 December 2020

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

12 December 2020

Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists.

1 reference

12 December 2020

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

1 reference

12 December 2020

Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy

1 reference

12 December 2020

Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex

1 reference

12 December 2020

The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine

1 reference

12 December 2020

A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.

1 reference

12 December 2020

alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs

1 reference

12 December 2020

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.

1 reference

12 December 2020

The glutamatergic nerve terminal

1 reference

12 December 2020

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1 reference

12 December 2020

Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats.

1 reference

12 December 2020

GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01271550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8695042%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference